September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Nicholas DeVito: Duke’s first-line immunotherapy trial for advanced/metastatic CRC is still enrolling
Apr 22, 2025, 14:05

Nicholas DeVito: Duke’s first-line immunotherapy trial for advanced/metastatic CRC is still enrolling

Nicholas DeVitoAssistant Professor of Medicine at the Division of Medical Oncology at Duke University, shared a post on LinkedIn:

“Our first-line immunotherapy (botensilimab/balstilimab) trial for advanced/metastatic colorectal cancer without liver, bone, or brain metastasis is still enrolling!

This trial is supported by Gateway for Cancer Research, Duke CRUSH CRC, and patient philanthropy.

Learn more about the BBOpCo trial here.”